Consortium

The European Project V|LF-Spiro3D is carried out by 10 partners from 4 countries: France, Netherland, Germany and UK. The project partners are Université Paris-Saclay (UPSaclay), Institut Polytechnique de Paris (IPP), Siemens healthcare SAS (Siemens), NMR Service GMBH (NMRS), Universiteit Van Tilburg (Tilburg), Universitair Medisch Centrum Rotterdam (Erasmus), Association Hopital Foch (Foch), Assistance Publique Hopitaux de Paris (APHP), Pole de Ressources en Education Therapeuthique du Patient (POLEPT) and University of Aberdeen (AMT) as an associated partner. 

Partners

Université Paris-Saclay

UPSaclay is beneficiary and the
coordinator of the project

Institut Polytechnique
de Paris

IPP is a project beneficiary

Siemens Healthineers

Siemens is a project beneficiary

NMR Service GMBH

NMRS is a project beneficiary

Tilburg University

Tilburg is a project beneficiary

Erasmus MC

Erasmus is a project beneficiary

Association Hospital Foch

Foch is a project beneficary

APHP Paris

APHP is a project beneficiary

POLETP

POLETP is a project benefeciary

Aberdeen University

AMT is an project associated partner

V|LF-Spiro3D aims at developing and validating a new modality for spatially resolved, 3D lung structure and function characterization using cost-effective small-footprint, low and very-low MRI technology.

OBJECTIVES

Acquire

Develop

Build

Investigate

INTERACTIONS

Recruitment

Press

Contact

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101099934. This communication reflects only the author’s view and the Commission is not responsible for any use that may be made of the information it contains.

Privacy Policy I Cookie Policy
© 2023 V|LF-Spiro3D | Design marion-jolly.com